| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |